Squamous Cell Transformation and EGFR T790M Mutation as Acquired Resistance Mechanisms in a Patient With Lung Adenocarcinoma Treated With a Tyrosine Kinase Inhibitor: A Case Report

Oncology Letters - Greece
doi 10.3892/ol.2017.6913
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Mechanisms of Acquired Resistance to EGFR-tyrosine Kinase Inhibitor in Korean Patients With Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

P3.01-002 Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient With EGFR TKI Drug Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Case Report: Temporal Heterogeneity of Resistance Mechanisms to EGFR-TKI Identified in a Lung Adenocarcinoma Patient With Sarcomatoid Transformation

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Newly Emergent Acquired EGFR Exon 18 G724S Mutation After Resistance of a T790M Specific EGFR Inhibitor Osimertinib in Non-Small-Cell Lung Cancer: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2018English

P3.17-14 a Case of a Patient Harboring an EGFR -T790m Mutation Positive in Squamous Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Association of Acquired T790M Mutation With Clinical Characteristics After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Cancer Research and Treatment
Cancer ResearchOncology
2018English

Adenocarcinoma of the Lung With EGFR Gene Mutation and Subsequent Resistance Mechanisms Exploration: Case Report

OncoTargets and Therapy
OncologyPharmacology
2017English

A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

OncoTargets and Therapy
OncologyPharmacology
2015English

EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy